13.4. Analysis.
Comparison 13 Tezacaftor (100 mg once daily) plus ivacaftor (150 mg twice daily) versus either placebo or ivacaftor (150 mg twice daily) alone, Outcome 4 Most common adverse events (occurring in at least 10% of participants in either group).